Chest mechanics after endoscopic lung volume reduction: Comparison between responders and non-responders based on dynamic hyperinflation - 05/08/25
, Silvia Perez-Bogerd a, Alain Van Muylem a, Pierre Alain Gevenois a, Olivier Van Hove a, Benjamin Bondue a, Emmeline Brenard b, Dimitri Leduc aAbstract |
Background |
Endobronchial lung volume reduction (ELVR) improves lung function, exercise capacity, and quality of life in case of severe emphysema. Nevertheless, not all patients are improved by ELVR including those with substantially decreased lung volume. We tested the hypothesis that unilateral volume loss could impact differently both responders and non-responders.
Methods |
A retrospective analysis was performed on 20 patients, classified as 13 responders and 7 non-responders based on inspiratory capacity increase ≥200 ml at isotime. We compared changes in lung volume, diaphragm shape and strength, mediastinal shift, lung function, exercise capacity, and quality of life before and three months after ELVR.
Results |
Compared to non-responders, responders showed a more improved diaphragm strength (4 vs. 2 cmH2O, p = 0.0318) and shape in both sides (non-treated side total area: +42 (7–54) cm2, p = 0.0079, non-treated side zone of apposition: +26 (18–52) cm2, p = 0.0270). Responders had a larger mediastinal shift than non-responders (13 vs. 3 degrees, p = 0.0039) with significant positive correlations between mediastinal shift and improvements in lung function (FEV1: r = 0.48, p = 0.0365), exercise capacity (6MWD: r = 0.78, p < 0.0001, inspiratory capacity: r = 0.48, p = 0.0365), and quality of life (CAT: r=-0.58, p = 0.0096).
Conclusions |
Dynamic hyperinflation responders present a larger mediastinal shift than non-responders. This shift could be a marker of improved diaphragm shape and strength in both treated and non-treated sides.
Clinical trial registration |
NCT05799352
Le texte complet de cet article est disponible en PDF.Keywords : Endoscopic lung volume reduction, Pulmonary emphysema, Endobronchial valve, Diaphragm, Mediastinum
Abbreviations : 6MWD, CAT, CT, DH, DLCO, EELV, ELVR, FEV1, FRC, IC, PDitw, PFT, RV, TLC
Plan
Vol 88
Article 101194- novembre 2025 Retour au numéro
Article précédent
- Long-acting muscarinic antagonist versus leukotriene receptor antagonist as additional treatment in uncontrolled asthma patients used inhaled corticosteroids and long-acting β2 adrenergic agonist: a randomized phase 2 screening trial
- Fumiya Nihashi, Kazuki Furuhashi, Mitsuru Niwa, Hirotsugu Hasegawa, Yusuke Kaida, Mikio Toyoshima, Naoki Koshimizu, Toshihiro Shirai, Masato Fujii, Kazutaka Mori, Masaki Ikeda, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Masato Karayama, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Takafumi Suda
- Impact of Remdesivir on long-term outcomes in lung transplant recipients with SARS-CoV-2 infection: a retrospective cohort analysis
- Damiana-Maria Vulturar, Gaëlle Dauriat, Anne Gigandon, Pauline Pradère, Pierre Gazengel, Samuel Dolidon, Chahine Medraoui, Amir Hanna, Adrian Crutu, Liviu-Stefan Moaca, Laurène Cachera, Delphine Mitilian, Dominique Fabre, Elie Fadel, Olaf Mercier, Alban Le Monnier, Jérôme Le Pavec, Benoît Pilmis
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?